The Cancer Treatment And Research Communications is reputed journal publishes research related to Biochemistry, Genetics and Molecular Biology; Medicine. The ISSN of the journal is 24682942.
Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.
| Journal Title | Cancer Treatment and Research Communications |
|---|---|
| Publisher | Elsevier Ltd |
| Publication Country | United Kingdom |
| ISSN | 24682942 |
| Publication Area | Cancer Research (Q3); Oncology (Q3) |
| Publication Language | English |
| Review Process | Anonymous peer review |
| Scopus Indexed | Yes |
The Cancer Treatment And Research Communications is ranked in Q3.
The Cancer Treatment And Research Communications is indexed in: DOAJ, Scopus, PubMed, Embase, UGC CARE Group 2.
There is a fee to publish in the Cancer Treatment And Research Communications. The publication fee is 2050 USD.
The journal also offers a fee waiver policy.
The Cancer Treatment And Research Communications takes an average of 17 weeks to publish research papers.
The official website of the journal is https://www.journals.elsevier.com/cancer-treatment-and-research-communications.
Please visit only official website of the journal to submit research papers.